Related Experiment Video
Updated: Oct 11, 2025

10:06
Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
Published on: February 26, 2018
7.5K
Hypercalcaemia in Mycobacterium kansasii pulmonary infection
Robert Costigan Flowers1,2, Javier Ocampo3,2, Justin Krautbauer3,2
1University of Miami Health System, Miami, Florida, USA rbrtflwrs@gmail.com.
BMJ Case Reports
|December 1, 2021
Summary
A kidney transplant patient developed hypercalcemia due to Mycobacterium kansasii infection, despite normal calcitriol levels. This suggests an alternative mechanism for hypercalcemia in granulomatous infections.
Area of Science:
- Nephrology
- Infectious Diseases
- Endocrinology
Background:
- Hypercalcemia is a complex metabolic disturbance often associated with malignancy, immobilization, and granulomatous diseases.
- In granulomatous conditions, hypercalcemia is typically attributed to overproduction of calcitriol by activated macrophages.
- Understanding the diverse etiologies of hypercalcemia is crucial for effective patient management.
Observation:
- A 60-year-old kidney transplant recipient presented with generalized weakness and altered mental status.
- Investigations revealed pancytopenia, acute kidney injury, hypercalcemia, low parathyroid hormone (PTH), and normal calcitriol levels.
- Chest CT showed lung opacities; bronchoscopy identified *Mycobacterium kansasii*.
Findings:
- The patient's hypercalcemia persisted despite normal calcitriol levels, challenging the classical understanding of calcitriol-mediated hypercalcemia in granulomatous disease.
- Treatment with bisphosphonates, calcitonin, and antibiotics for non-tuberculous mycobacterial pulmonary infection led to improved calcium levels.
- This case highlights a potential non-calcitriol-dependent mechanism for hypercalcemia in mycobacterial infections.
Implications:
- The findings suggest an alternative pathway for hypercalcemia in granulomatous infections, beyond calcitriol overproduction.
- This case broadens the differential diagnosis for hypercalcemia in immunocompromised patients, particularly transplant recipients.
- Further research is warranted to elucidate the precise mechanisms of hypercalcemia in mycobacterial infections.
Related Concept Videos
Pulmonary Tuberculosis II
616
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
616
Pulmonary Tuberculosis III
508
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
508
Pulmonary Tuberculosis I
391
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
391
Pulmonary Tuberculosis IV
227
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
227
Pulmonary Tuberculosis V
264
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
264

